A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 and Letrozole vs + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Receptor-Positive, HER2-Negative Advanced

  • Breast Cancer